[To study the expression of dendritic cell phenotypic antigen in cervical lymph nodes in hypopharyngeal carcinoma]

Xiaoyan Li1, Tadashi Nakashima, Pin Dong

  • 1Department of Otolaryngology-Head and Neck Surgery, Shanghai Jiaotong University, First People's Hospital, China.

Lin Chuang Er Bi Yan Hou Ke Za Zhi = Journal of Clinical Otorhinolaryngology
|May 2, 2006
PubMed

Insights

Dendritic cell (DC) phenotypic antigens in hypopharyngeal carcinoma lymph nodes differ based on metastasis and prognosis. Lower expression of S-100, CD1a, and CD83+ DCs correlates with metastasis and poorer survival, indicating their prognostic value.

Area of Science:

  • Immunology
  • Oncology
  • Pathology

Context:

  • Dendritic cells (DCs) are crucial for antigen presentation and immune response.
  • Hypopharyngeal carcinoma is a significant head and neck cancer with variable prognosis.
  • Understanding immune cell markers in the tumor microenvironment is vital for predicting outcomes.

Purpose:

  • To investigate the expression of DC phenotypic antigens (S-100, CD1a, CD83) in cervical lymph nodes of hypopharyngeal carcinoma patients.
  • To evaluate the association between DC phenotypic antigen expression, lymph node metastasis, and patient prognosis.

Summary:

  • Reduced numbers of S-100+, CD1a+, and CD83+ DCs were observed in lymph node metastasis compared to non-metastatic cases.
  • CD83+ DCs were less abundant in cancerous nests than in peritumor areas within metastatic lymph nodes.
  • Higher CD83+ DC counts were associated with improved survival, and CD45RO+ T cells predominantly surrounded CD83+ DCs.

Impact:

  • DC phenotypic antigen expression provides significant differences in various lymph node areas, suggesting a role in anti-tumor immunity.
  • These DC markers are valuable indicators for predicting the prognosis of hypopharyngeal carcinoma patients.
  • This research aids in developing targeted immunotherapies and improving patient stratification.
Abstract

Related Concept Videos